Year: 2020

TORONTO and CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, today commented on the November 6th FDA Peripheral and Central Nervous System Drugs Advisory Committee meeting and its review of Biogen’s Biologics License Application (BLA) for aducanumab for the treatment of Alzheimer’s disease.The key BLA components reviewed at the advisory committee meeting consisted of three clinical trials: two pivotal phase 3 trials of similar design (Study 301, 302) and one phase 1b trial (Study 103). Both Biogen and FDA acknowledged Study 301 (ENGAGE) was negative and could not contribute to the evidence for aducanumab’s...

BROOKFIELD, NEWS, Nov. 09, 2020 (GLOBE NEWSWIRE) — Brookfield Infrastructure (NYSE: BIP; TSX: BIP.UN) today announced its results for the third quarter ended September 30, 2020.“Our businesses continued to demonstrate their resilience during the third quarter, with each segment delivering solid operating results. We have also benefited from the completion of two highly cash-generative investments that align with our current strategic focus,” said Sam Pollock, Chief Executive Officer of Brookfield Infrastructure Partners. “Looking ahead, we anticipate 2021 will be a year of meaningful growth for Brookfield Infrastructure. Our very strong liquidity position, along with the positive momentum being generated by our capital recycling program, should enhance our ability to execute on compelling opportunities.”Net income attributable to...

ROAD TOWN, British Virgin Islands, Nov. 09, 2020 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (the “Company” or “Aura”) today announces that, further to its press releases dated August 26, 2020, October 9, 2020 and October 29, 2020, the announcement of commencement (anúncio de início) has been released in connection with the secondary public offering of Brazilian depositary receipts (certificados de depósito de ações, or “BDRs”), issued by Itaú Unibanco S.A., as depositary, each BDR representing one share in the capital of the Company (each share of the Company, a “Share”), by Arias Resource Capital Fund L.P., Arias Resource Capital Fund II (Mexico) L.P. and Arias Resource Capital Fund II L.P. (collectively, the “ARC Funds”) and LF Ruffer Investment Funds – LF Ruffer Gold Fund (“Ruffer”), each as a selling shareholder...

BOSTON, Nov. 09, 2020 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton, today announced the appointment of Kevin B. Johnson, Ph.D., MBA, as senior vice president, regulatory affairs, effective immediately.Dr. Johnson brings to Inozyme more than 25 years of experience in developing and implementing global regulatory and clinical development strategies for rare diseases across entire product development lifecycles from preclinical through clinical development and ultimately to product approval for a variety of drugs, biologics, combination products and cell/gene therapies. Dr. Johnson will be responsible for leading Inozyme’s global regulatory strategy.“We...

SAN CARLOS, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of cybersecurity solutions globally, has introduced its next-generation unified cyber security platform, Check Point R81. The new platform is the industry’s first to deliver autonomous threat prevention designed for the entire distributed enterprise, enabling IT staff to manage the most complex and dynamic network environments easily and efficiently.Enterprises have accelerated their digital transformation programs and changed IT priorities in response to the Covid-19 pandemic, which has increased their cyber risk exposure and risen the complexity of managing employees remotely. Seventy one percent of security professionals reported an increase in cyber threats since the beginning of the pandemic. Addressing...

VIENNA, Austria, Nov. 09, 2020 (GLOBE NEWSWIRE) — Tyson Foods, Inc. (NYSE: TSN) today announced the European launch of its plant-based protein brand, Raised & Rooted™. This is the first expansion of the Raised & Rooted brand outside the U.S., in the brand’s pursuit to be the most loved alternative protein brand in the world.“We’re thrilled to be launching Raised & Rooted in Europe, where there is a growing number of consumers who are adopting flexible diets,” said Brett Van de Bovenkamp, president of Tyson Foods Europe. “Our unique capabilities in R&D and innovation, combined with our international footprint and infrastructure makes us uniquely positioned to be a European market leader in alternative protein.”The European Raised & Rooted range, which include five varieties of plant-based products, will be...

SAN JOSE, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — Forescout Technologies, Inc., the leader in Enterprise of Things security, today announced Merlin International, Inc. as the recipient of its U.S. Partner of the Year Award. This award recognizes channel partners for excellence in performance, collaboration and commitment to joint customers. Merlin, a valued Forescout partner since 2016, delivers cybersecurity solutions, innovative technology and intelligence capabilities to organizations in highly regulated industries.“We are pleased to announce Merlin International as Partner of the Year. Through a combination of strong technical and industry expertise and streamlined, integrated solutions that secure the entire extended enterprise – from IoT to OT to the cloud – Merlin has excelled in driving Forescout sales and increasing Forescout’s...

SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”, or the “Company”), announced that GBT Tokenize (“GBT/Tokenize”) commenced a new radio system development for its qTerm device.The new radio system is aimed to enable qTerm as a private, secured, MESH radio communication network. GBT/Tokenize has developed the technology for a radio based network that can be used for IoT and mobile devices. A successful MESH network system was tested in 2019.This new radio system will be implemented as communication circuits to enable direct communication between qTerm devices outside the BLE (Low Energy Bluetooth) radio system. The system is planned to communicate using its own radio channel, creating a MESH network between qTerm devices and will work within its own, private, secured communication protocol.GBT/Tokenize...

Presented additional data from XMT-1536 Phase 1 study at ESMO demonstrating compelling and consistent activity and tolerability profile in ovarian cancerReceived FDA Fast Track Designation for XMT-1536 for patients with heavily-pretreated ovarian cancerEnded Q3 2020 with $271 million in cashCAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today reported financial results and provided a business update for the third quarter ended September 30, 2020.“During the quarter, we presented an update from the ovarian cancer cohort of the XMT-1536 Phase 1 study at ESMO, which showed continued significant anti-tumor activity...

Som annonceret i selskabsmeddelelse 33/2020 har SIG påbegyndt et aktietilbagekøbsprogram som løber i perioden fra og med den 31. august 2020 til og med den 9. november 2020.I denne periode vil Selskabet købe egne aktier op til maksimalt 15,0% af aktiekapitalen i et aktietilbagekøbsprogram efter bestemmelserne i EU’s forordning nr. 596/2014 af 16. april 2014 og EU’s forordning nr. 2016/1052 om supplerende regler til forordning nr. 596/2014, den såkaldte ”Safe Harbour” metode, som værner børsnoterede selskaber og deres bestyrelse og direktion imod overtrædelse af forbuddene mod markedsmisbrug i forbindelse med aktie­tilbagekøb.Vedhæftede transaktioner er foretaget under dette program.Ovennævnte beskrevne aktietilbagekøbsprogram er hermed slut.Efter ovennævnte transaktioner ejer Scandinavian Investment Group A/S 6.565.152 egne aktier, svarende...